Intuitive Surgical (NASDAQ:ISRG) Receives "Outperform" Rating from Royal Bank Of Canada

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Intuitive Surgical (NASDAQ:ISRG - Get Free Report)'s stock had its "outperform" rating reaffirmed by equities researchers at Royal Bank Of Canada in a report issued on Tuesday,Benzinga reports. They currently have a $615.00 target price on the medical equipment provider's stock. Royal Bank Of Canada's price objective would indicate a potential upside of 26.94% from the company's previous close.

ISRG has been the subject of several other research reports. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, BTIG Research lifted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Stock Up 0.7%

Shares of NASDAQ ISRG traded up $3.21 during mid-day trading on Tuesday, reaching $484.49. 245,209 shares of the company were exchanged, compared to its average volume of 1,981,725. The company's 50-day simple moving average is $507.85 and its 200-day simple moving average is $524.14. The stock has a market capitalization of $173.68 billion, a P/E ratio of 67.57, a P/E/G ratio of 5.03 and a beta of 1.59. Intuitive Surgical has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.78 EPS. As a group, equities research analysts expect that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 7,893 shares of the business's stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $498.64, for a total value of $3,935,765.52. Following the transaction, the insider owned 13,187 shares in the company, valued at approximately $6,575,565.68. The trade was a 37.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,839 shares of company stock worth $7,896,972. Company insiders own 0.70% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Chilton Capital Management LLC lifted its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares in the last quarter. Tobam increased its holdings in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider's stock worth $25,000 after buying an additional 40 shares during the last quarter. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. Global Financial Private Client LLC increased its holdings in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after buying an additional 38 shares during the last quarter. Finally, Elite Financial Inc. purchased a new stake in Intuitive Surgical during the first quarter worth about $26,000. Institutional investors and hedge funds own 83.64% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.